Looking back: One year ago, Erie was at the center of the solar eclipse's path of totality
People came from near and far to witness a celestial phenomenon that won't occur again until Aug. 22, 2044. And that total solar eclipse won't be visible in Erie.
Roughly 100,000 visitors found spots throughout the Erie region to catch the eclipse, which lasted nearly 2½ hours from beginning of partial phases to totality and finish. The total eclipse started at 3:16 p.m. in the city and lasted approximately 3 minutes, 39 seconds.
Revisit coverage from GoErie.com and the Times-News of that historic day:
Reporters from GoErie.com and the Pennsylvania's USA TODAY Network were among the sky watchers in crowds at several viewing events in Erie County and beyond. People from around the globe visited Erie for eclipse.
There was an eclipse wedding at Frontier Park, vendors all around Erie, a Gov. Josh Shapiro visit to Perry Square and UPMC Park, and events in locations throughout the county.
Roughly 100,000 people from Nepal, Germany and across the country came to Erie, according to VisitErie. But the gray skies and light rains might have kept some at home while others headed west in search of better weather on April 8, 2024.
"It wasn't just Erie," said John Oliver, CEO of VisitErie. "We noted that, along with others along the path of totality, that attendance still wasn't as high as we thought it might have gone. The weather was a factor."
That didn't get to watch it, but there were even a few babies born in Erie on eclipse day.
From the beaches of Presque Isle State Park to vineyards of North East, crowds cheered as the moon obscured the sun and made Erie a hot destination from visitors from across the country.
From the smallest of backyards to the biggest of venues — including Frontier Park, Lake Erie Speedway, UPMC Park, Perry Square, Presque Isle State Park and the remote Erie National Wildlife Refuge in Crawford County — viewers wore their ISO-certified glasses and looked to the heavens.
No one can accuse the community of failing to plan. For more than a year, leaders from tourism, law enforcement, the business community, education and local government worked to ensure that Erie seized the cosmic moment.
The Times-News provided everything residents and visitors needed to know, from the weather and traffic, to details on more than 40 different watch events during the eclipse.
This article originally appeared on Erie Times-News: Solar eclipse a year later: Erie thrived during moment of totality

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
8 hours ago
- Business Wire
Communication Matters More Than Ever During Global Events Like FIFA 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--With the FIFA World Cup set to arrive in North America next summer, businesses across the continent—especially in host cities like Toronto and Vancouver—are preparing for a wave of global attention. Beyond managing logistics and crowds, communication is key to delivering a successful experience for all. 'Communication is central,' said John Furlong, former head of Vancouver's 2010 Olympic Organizing Committee (VANOC), in a recent CTV interview. LAT Multilingual worked closely with VANOC at the time, ensuring all communications were translated promptly. Now, the team is once again ready to support businesses and destinations in making FIFA 2026 a memorable success. 'In the months leading up to the World Cup, locals and visitors need to understand what's coming and how they can make the most of this major event,' said Julie Wong-Gravend, President of LAT Multilingual. 'Multilingual and culturally relevant communication is essential.' From signage and menus to websites and digital campaigns, clear and inclusive communication fosters understanding. It also creates opportunities for destinations beyond host cities to engage travellers planning extended stays or day trips during the tournament. Global events require globally minded strategies. To connect effectively, content must be adapted to reach people in their own language and on their preferred platforms. Translation, campaign localization, multilingual social media, and cultural training are all essential parts of a truly global communication approach. 'Global visibility starts with local readiness,' Wong-Gravend added. 'Businesses can play a meaningful role in creating a welcoming environment for visitors by showing up in the right language, on the right platform, and with the right tone.' About LAT Multilingual Founded in 1999, LAT Multilingual is a women-owned, ISO-certified, B Corp company specializing in translation, cultural adaptation, and multicultural marketing. With offices in Vancouver, Montreal, and Toronto, LAT helps organizations of all sizes connect authentically with diverse audiences. By combining linguistic expertise with culturally informed strategies, LAT delivers trusted quality, meaningful results, and a commitment to ethical, inclusive business practices.


Business Wire
9 hours ago
- Business Wire
BostonGene Publishes Landmark Study Providing Clinical and Analytical Validation for Its Multimodal RNA and DNA Assay
WALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, ' Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort, ' in Communications Medicine, a high-impact journal in the Nature portfolio. The study underscores the BostonGene Tumor Portrait™ assay as a clinically robust, regulatory-grade platform that forms the foundation of BostonGene's AI-powered platform, purpose-built for precision oncology and designed to accelerate therapeutic development and enhance clinical data collection. 'Delivering clinically validated multimodal data from a single tumor sample—and interpreting it through an immune-focused, AI-enabled lens—represents a transformative advancement for oncology drug development.' The Tumor Portrait™ assay integrates DNA and RNA sequencing into a single end-to-end test, delivering a multimodal view of each tumor. Approved under CLIA, CAP and the New York State Department of Health, the platform enhances patient stratification, predictive biomarker discovery and clinical trial enrollment—all critical to reducing the risks associated with drug development and improving clinical trial success rates. The study details the implementation of highly stable clinical RNA-seq protocol, deployed in ready-to-use clinical settings and tested across more than 2,200 tumors, demonstrating high reproducibility, strong clinical actionability (98% of cases) and advanced detection of alterations, fusions, immune signatures, tumor microenvironment profiles and AI-based predictive classifications. 'Delivering clinically validated multimodal data from a single tumor sample—and interpreting it through an immune-focused, AI-enabled lens—represents a transformative advancement for oncology drug development,' said Alexander Bagaev, PhD, Chief Product Officer at BostonGene. 'By combining DNA and RNA sequencing in one assay, our platform enables deeper biological understanding of the tumor microenvironment and genetics, smarter patient selection and more confident, data-driven decisions throughout the drug development lifecycle. This validation sets a new benchmark for translational research and diagnostic innovation.' About BostonGene Corporation BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit


The Verge
11 hours ago
- The Verge
RFK Jr.: ‘Trusting the experts is not science.'
Posted Aug 12, 2025 at 12:07 PM UTC Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates. Jess Weatherbed Posts from this author will be added to your daily email digest and your homepage feed. See All by Jess Weatherbed Posts from this topic will be added to your daily email digest and your homepage feed. See All Health Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Policy Posts from this topic will be added to your daily email digest and your homepage feed. See All Science